Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn's Disease: A Case Report
- PMID: 31320810
- PMCID: PMC6610429
- DOI: 10.1177/1179547619858979
Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn's Disease: A Case Report
Abstract
Herpes simplex virus (HSV) hepatitis is an uncommon cause of fulminant hepatic failure, seen mostly in immunocompromised patients. Conventional treatment modalities for inflammatory bowel disease (IBD), such as steroids and azathioprine, have been known to cause HSV hepatitis. However, the reported incidence of HSV hepatitis in IBD patients undergoing tumor necrosis factor (TNF)-α inhibitor therapy is very rare. In this case report, we describe a rare case of fulminant HSV hepatitis that developed in a patient with Crohn's disease after treatment with the TNF-α inhibitor, adalimumab.
Keywords: Crohn’s disease; TNF-α inhibitor; adalimumab; hepatitis; herpes simplex virus; inflammatory bowel disease.
Conflict of interest statement
Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Schiodt FV, Davern TJ, Shakil AO, McGuire B, Samuel G, Lee WM. Viral hepatitis-related acute liver failure. Am J Gastroenterol. 2003;98:448–453. - PubMed
-
- Haag LM, Hofmann J, Kredel LI, et al. Herpes simplex virus sepsis in a young woman with Crohn’s disease. J Crohns Colitis. 2015;9:1169–1173. - PubMed
-
- Kaufman B, Gandhi SA, Louie E, Rizzi R, Illei P. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis. 1997;24:334–338. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
